Home / Health / Ranitidine tablets banned

Ranitidine tablets banned

Ranitidine tablets banned

The drug authority in Bangladesh banded the product on Sunday after GlaxoSmithKline Pharmaceuticals’ voluntary recall of Ranitidine tablets produced in India following an alleged detection of genotoxic nitrosamine NDMA by global and Indian regulatory authorities.

The import of raw material for making Ranitidine hydrochloride tablets from India’s Saraca Laboratories Ltd has also been temporarily banned.Major General Md Mahbubur Rahman, Director General of the Drug Administration, confirmed the news on Sunday.